FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205206744> ?p ?o ?g. }

• W4205206744 endingPage "1189" @default.
• W4205206744 startingPage "1178" @default.
• W4205206744 abstract "Metabolomics facilitates the discovery of biomarkers and potential therapeutic targets for CKD progression.We evaluated an untargeted metabolomics quantification of stored plasma samples from 645 Chronic Kidney Disease in Children (CKiD) participants. Metabolites were standardized and logarithmically transformed. Cox proportional hazards regression examined the association between 825 nondrug metabolites and progression to the composite outcome of KRT or 50% reduction of eGFR, adjusting for age, sex, race, body mass index, hypertension, glomerular versus nonglomerular diagnosis, proteinuria, and baseline eGFR. Stratified analyses were performed within subgroups of glomerular/nonglomerular diagnosis and baseline eGFR.Baseline characteristics were 391 (61%) male; median age 12 years; median eGFR 54 ml/min per 1.73 m2; 448 (69%) nonglomerular diagnosis. Over a median follow-up of 4.8 years, 209 (32%) participants developed the composite outcome. Unique association signals were identified in subgroups of baseline eGFR. Among participants with baseline eGFR ≥60 ml/min per 1.73 m2, two-fold higher levels of seven metabolites were significantly associated with higher hazards of KRT/halving of eGFR events: three involved in purine and pyrimidine metabolism (N6-carbamoylthreonyladenosine, hazard ratio, 16; 95% confidence interval, 4 to 60; 5,6-dihydrouridine, hazard ratio, 17; 95% confidence interval, 5 to 55; pseudouridine, hazard ratio, 39; 95% confidence interval, 8 to 200); two amino acids, C-glycosyltryptophan, hazard ratio, 24; 95% confidence interval 6 to 95 and lanthionine, hazard ratio, 3; 95% confidence interval, 2 to 5; the tricarboxylic acid cycle intermediate 2-methylcitrate/homocitrate, hazard ratio, 4; 95% confidence interval, 2 to 7; and gulonate, hazard ratio, 10; 95% confidence interval, 3 to 29. Among those with baseline eGFR <60 ml/min per 1.73 m2, a higher level of tetrahydrocortisol sulfate was associated with lower risk of progression (hazard ratio, 0.8; 95% confidence interval, 0.7 to 0.9).Untargeted plasma metabolomic profiling facilitated discovery of novel metabolite associations with CKD progression in children that were independent of established clinical predictors and highlight the role of select biologic pathways." @default.
• W4205206744 created "2022-01-26" @default.
• W4205206744 creator A5016894949 @default.
• W4205206744 creator A5025948477 @default.
• W4205206744 creator A5027825347 @default.
• W4205206744 creator A5033395115 @default.
• W4205206744 creator A5034619560 @default.
• W4205206744 creator A5040726727 @default.
• W4205206744 creator A5047227825 @default.
• W4205206744 creator A5050985673 @default.
• W4205206744 creator A5056623045 @default.
• W4205206744 creator A5061721045 @default.
• W4205206744 creator A5069919544 @default.
• W4205206744 creator A5075115334 @default.
• W4205206744 creator A5084477412 @default.
• W4205206744 date "2021-08-01" @default.
• W4205206744 modified "2023-10-16" @default.
• W4205206744 title "Metabolite Biomarkers of CKD Progression in Children" @default.
• W4205206744 cites W1563895570 @default.
• W4205206744 cites W1980270094 @default.
• W4205206744 cites W1992967220 @default.
• W4205206744 cites W2005359013 @default.
• W4205206744 cites W2005438826 @default.
• W4205206744 cites W2024825620 @default.
• W4205206744 cites W2027852347 @default.
• W4205206744 cites W2030777261 @default.
• W4205206744 cites W2032773600 @default.
• W4205206744 cites W2034401134 @default.
• W4205206744 cites W2041899030 @default.
• W4205206744 cites W2048551699 @default.
• W4205206744 cites W2059229152 @default.
• W4205206744 cites W2068797950 @default.
• W4205206744 cites W2097320597 @default.
• W4205206744 cites W2098689822 @default.
• W4205206744 cites W2100619505 @default.
• W4205206744 cites W2122855609 @default.
• W4205206744 cites W2124822019 @default.
• W4205206744 cites W2133740866 @default.
• W4205206744 cites W2136284582 @default.
• W4205206744 cites W2153668464 @default.
• W4205206744 cites W2153929684 @default.
• W4205206744 cites W2180331025 @default.
• W4205206744 cites W2189612961 @default.
• W4205206744 cites W2218946625 @default.
• W4205206744 cites W2328615536 @default.
• W4205206744 cites W2343748894 @default.
• W4205206744 cites W2380380353 @default.
• W4205206744 cites W2479654766 @default.
• W4205206744 cites W2525639156 @default.
• W4205206744 cites W2556848521 @default.
• W4205206744 cites W2570725032 @default.
• W4205206744 cites W2572861075 @default.
• W4205206744 cites W2731800117 @default.
• W4205206744 cites W2762198627 @default.
• W4205206744 cites W2763873366 @default.
• W4205206744 cites W2797187174 @default.
• W4205206744 cites W2803161655 @default.
• W4205206744 cites W2806565977 @default.
• W4205206744 cites W2891048467 @default.
• W4205206744 cites W2911722764 @default.
• W4205206744 cites W2944412030 @default.
• W4205206744 cites W2982711130 @default.
• W4205206744 cites W3025584109 @default.
• W4205206744 doi "https://doi.org/10.2215/cjn.00220121" @default.
• W4205206744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34362785" @default.
• W4205206744 hasPublicationYear "2021" @default.
• W4205206744 type Work @default.
• W4205206744 citedByCount "12" @default.
• W4205206744 countsByYear W42052067442021 @default.
• W4205206744 countsByYear W42052067442022 @default.
• W4205206744 countsByYear W42052067442023 @default.
• W4205206744 crossrefType "journal-article" @default.
• W4205206744 hasAuthorship W4205206744A5016894949 @default.
• W4205206744 hasAuthorship W4205206744A5025948477 @default.
• W4205206744 hasAuthorship W4205206744A5027825347 @default.
• W4205206744 hasAuthorship W4205206744A5033395115 @default.
• W4205206744 hasAuthorship W4205206744A5034619560 @default.
• W4205206744 hasAuthorship W4205206744A5040726727 @default.
• W4205206744 hasAuthorship W4205206744A5047227825 @default.
• W4205206744 hasAuthorship W4205206744A5050985673 @default.
• W4205206744 hasAuthorship W4205206744A5056623045 @default.
• W4205206744 hasAuthorship W4205206744A5061721045 @default.
• W4205206744 hasAuthorship W4205206744A5069919544 @default.
• W4205206744 hasAuthorship W4205206744A5075115334 @default.
• W4205206744 hasAuthorship W4205206744A5084477412 @default.
• W4205206744 hasBestOaLocation W42052067441 @default.
• W4205206744 hasConcept C126322002 @default.
• W4205206744 hasConcept C143998085 @default.
• W4205206744 hasConcept C159641895 @default.
• W4205206744 hasConcept C207103383 @default.
• W4205206744 hasConcept C44249647 @default.
• W4205206744 hasConcept C50382708 @default.
• W4205206744 hasConcept C71924100 @default.
• W4205206744 hasConceptScore W4205206744C126322002 @default.
• W4205206744 hasConceptScore W4205206744C143998085 @default.
• W4205206744 hasConceptScore W4205206744C159641895 @default.
• W4205206744 hasConceptScore W4205206744C207103383 @default.
• W4205206744 hasConceptScore W4205206744C44249647 @default.

• next